Dr. Dalane Kitzman and Dr. C. Michael Gibson Discuss: A Novel Physical Rehabilitation Intervention For Older Patients With Acute Decompensated Heart Failure: The REHAB-HF Trial May 15, 2021
Dr. Mikhail Kosiborod and Dr. C. Michael Gibson Discuss: Effects Of Dapagliflozin On Prevention Of Major Clinical Events And Recovery In Patients With Respiratory Failure Due To COVID-19 – Main Results From The DARE-19 Randomized Trial May 15, 2021 Disclosures: TBD
Dr. Richard Whitlock and Dr. C. Michael Gibson Discuss: The Left Atrial Appendage Occlusion Study (LAAOS) III May 15, 2021 Disclosures: TBD
Dr. Schuyler Jones, Mr. Greg Merritt, and Dr. C. Michael Gibson Discuss: Aspirin Dosing: A Patient-centric Trial Assessing Benefits And Long-term Effectiveness Trial May 15, 2021 Disclosures: TBD
Dr. Eugene Braunwald and Dr. C. Michael Gibson Discuss: Prospective Arni Versus Ace Inhibitor Trial To Determine Superiority In Reducing Heart Failure Events After Myocardial Infarction (paradise-mi) May 15, 2021 Disclosures: TBD
Dr. Rupert Bauersachs and Dr. C. Michael Gibson Discuss: Reductions In Total Ischemic Events With Rivaroxaban In Patients With Symptomatic Pad After Revascularization: The VOYAGER PAD Trial May 15, 2021 Disclosures: TBD
Dr. John Teerlink and Dr. C. Michael Gibson Discuss: Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: The Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure (GALACTIC-HF) Trial November 17, 2020 Disclosures: TBA
Dr. Deepak Bhatt and Dr. C. Michael Gibson Discuss: Divergent Results in the STRENGTH and REDUCE-IT trials November 16, 2020 Disclosures: TBA
